Critical evaluation of latanoprostene bunod in the treatment of glaucoma

Critical evaluation of latanoprostene bunod in the treatment of glaucoma

Giancarlo A Garcia, Philip Ngai, Sameh Mosaed, Ken Y Lin Department of Ophthalmology, Gavin Herbert Eye Institute, University of California, Irvine, Irvine, CA, USA Abstract: Latanoprostene bunod (LBN) is a novel nitric oxide-donating prostaglandin F2α receptor agonist in clinic...

Full description

Bibliographic Details
Main Authors: Garcia GA, Ngai P, Mosaed S, Lin KY
Format: Article
Language:English
Published: Dove Medical Press 2016-10-01
Series:Clinical Ophthalmology
Subjects:
uveoscleral outflow
glaucoma medical treatment
ocular hypertension
latanoprostene bunod
nitric oxide
clinical trial
Online Access:https://www.dovepress.com/critical-evaluation-of-latanoprostene-bunod-in-the-treatment-of-glauco-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/critical-evaluation-of-latanoprostene-bunod-in-the-treatment-of-glauco-peer-reviewed-article-OPTH

Similar Items